Relatively novel AKI biomarkers like sTNFR1, sTNFR2, S100P, CD 26 and KRK1 in urine and plasma have been introduced, hence showing some promising results in AKI stratification and their association with severity and progression. This evidence concerns the gene S100P and acute kidney injury.